Author
Listed:
- Agnieszka Czarniecka
- Monika Kowal
- Dagmara Rusinek
- Jolanta Krajewska
- Michal Jarzab
- Ewa Stobiecka
- Ewa Chmielik
- Ewa Zembala-Nozynska
- Stanislaw Poltorak
- Aleksander Sacher
- Adam Maciejewski
- Jadwiga Zebracka-Gala
- Dariusz Lange
- Malgorzata Oczko-Wojciechowska
- Daria Handkiewicz-Junak
- Barbara Jarzab
Abstract
Introduction: The risk of over-treatment in low-advanced PTC stages has prompted clinicians to search for new reliable prognostic factors. The presence of BRAF mutation, the most frequent molecular event in PTC, seems to be a good candidate. However, there is still lack of randomised trials and its significance has been proved by retrospective analyses, involving a large group of patients. The question arises whether this factor is useful in smaller populations, characterised for specialised centres. Thus, the aim of the study was to evaluate the use of BRAF mutation as a potential predictive marker in PTC patients. Material: 233 PTC subjects treated between 2004-2006, were retrospectively analysed. Stage pT1 was diagnosed in 64.8% patients and lymph node metastases in 30.9%. Median follow-up was 7.5 years. BRAFV600E mutation was assessed postoperatively in all cases. Results: BRAF V600E mutation was found in 54.5%. It was more frequent in patients > 45 years (p=0.0001), and associated with larger tumour size (p=0.004). Patients with tumours
Suggested Citation
Agnieszka Czarniecka & Monika Kowal & Dagmara Rusinek & Jolanta Krajewska & Michal Jarzab & Ewa Stobiecka & Ewa Chmielik & Ewa Zembala-Nozynska & Stanislaw Poltorak & Aleksander Sacher & Adam Maciejew, 2015.
"The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors,"
PLOS ONE, Public Library of Science, vol. 10(7), pages 1-14, July.
Handle:
RePEc:plo:pone00:0132821
DOI: 10.1371/journal.pone.0132821
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0132821. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.